Avalon GloboCare Corp.
Avalon GloboCare Corp. (Nasdaq: ALBT) is a clinical-stage biotechnology company dedicated to develop and deliver innovative and transformative CellTech with multifunctional convergence in cellular technologies/therapeutics, precision diagnostics and intellectual property in the field of immuno-oncology and cellular medicines.
IR Website: https://ir.avalon-globocare.com/
Headquarters: Freehold, NJ
The company’s core technology platforms include cellular therapies (CAR-T, CAR-NK, mRNA-based Flash-CARTM), Avalon clinical-grade tissue-specific exosomes (ACTEXTM), and precision companion diagnostics related to cellular medicines.
TALK TO MANAGEMENT
The Avalon Globocare management team is always available to talk to current and potential investors. They're happy to answer any questions you may have and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
Stock Chart (Intraday)
Stock Chart (Historical)
Video: Bezinga Presents an Interview with Avalon GloboCare
CAR-T Cells and Their Transformational Promise
CAR-T Market Size
Exosomes - What Are They and How is ALBT Using Them?
Regenerative Therapy Market
Board of Directors and Advisory Board
Senior Management Bios
Risks & Disclosures
The Avalon GloboCare Corp. management and investor relations team is available to talk to current and potential investors. They're happy to answer your questions and tell you what makes their story unique. Please fill out this form, and we will connect you shortly.
• Directly hear the Avalon GloboCare Corp. story
• Ask your questions
• Submit the form below and someone will get in touch with you as soon as possible
Note: Company management or its representative can only discuss and disclose information that is already available in the public domain. They will do their best to clarify such information to the extent permitted by securities law and industry regulations.